The global CBD consumer health market size was valued at USD 25.7 billion in 2025 and is projected to grow from USD 29.8 billion in 2026 to USD 89.7 billion in 2033, at a CAGR of 17.1% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 65.0% in 2025, driven by the increasing number of positive government reforms for legalizing cannabidiol (CBD) in various regions worldwide. CBD consumer products are gaining significant acceptance due to rising awareness of their health benefits. Furthermore, the demand for hemp-derived CBD products is increasing globally due to the legalization of hemp in various countries.
Cannabidiol (CBD) has gained popularity in dietary supplements due to its health benefits and non-narcotic properties. Unlike Tetrahydrocannabinol (THC), CBD provides users with the advantages of cannabis without causing intoxication. Many people believe that CBD supplements offer more natural alternatives to prescription and over-the-counter medications for alleviating stiffness, pain, anxiety, stress, and various medical conditions. Manufacturers often prefer hemp-derived CBD because it contains a low concentration of THC. Favorable regulations on hemp cultivation in countries such as the U.S., Canada, China, India, the UK, and several European nations have supported the rising demand for hemp-derived CBD products and boosted exports from these countries.
The popularity of cannabidiol is also a reflection of shifting cultural perceptions and its recognized health benefits. Additionally, the innovative marketing and advertising strategies employed by leading companies have significantly increased product demand. As a result, there has been a noticeable expansion in consumer product options, including topicals, analgesics, edibles, oils, tinctures, and many more, driving substantial growth in this market. Moreover, growing awareness of the health benefits of CBD-infused products has increased consumers' willingness to purchase them, regardless of price.
In response to this surge in demand, mainstream retailers that once focused on non-CBD products are now shifting their attention to CBD-based offerings, attracted by higher profit margins and sales. For instance, in March 2023, CV Sciences, Inc., a U.S.-based wellness company that sells hemp extracts and other natural ingredients, announced the addition of +PlusCBD Daily Balance THC-Free Gummies and Softgels to its product line, providing consumers with the wellness benefits of CBD. Such developments have become increasingly common in recent years, fueled by legalization and a positive stance from health authorities and governments in the industry.
▪ CBD Dermatology Products
▪ CBD Mental Health Products
▪ CBD Sleeping Aids Products
▪ Other OTC Products
▪ CBD Sports Nutrition
▪ CBD Weight Management and Wellbeing
▪ Canada
▪ Mexico
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
▪ India
▪ China
▪ Australia
▪ South Korea
▪ Thailand
▪ Argentina
▪ Saudi Arabia
▪ UAE
▪ Kuwait
Cannabidiol (CBD) has gained popularity in dietary supplements due to its health benefits and non-narcotic properties. Unlike Tetrahydrocannabinol (THC), CBD provides users with the advantages of cannabis without causing intoxication. Many people believe that CBD supplements offer more natural alternatives to prescription and over-the-counter medications for alleviating stiffness, pain, anxiety, stress, and various medical conditions. Manufacturers often prefer hemp-derived CBD because it contains a low concentration of THC. Favorable regulations on hemp cultivation in countries such as the U.S., Canada, China, India, the UK, and several European nations have supported the rising demand for hemp-derived CBD products and boosted exports from these countries.
The popularity of cannabidiol is also a reflection of shifting cultural perceptions and its recognized health benefits. Additionally, the innovative marketing and advertising strategies employed by leading companies have significantly increased product demand. As a result, there has been a noticeable expansion in consumer product options, including topicals, analgesics, edibles, oils, tinctures, and many more, driving substantial growth in this market. Moreover, growing awareness of the health benefits of CBD-infused products has increased consumers' willingness to purchase them, regardless of price.
In response to this surge in demand, mainstream retailers that once focused on non-CBD products are now shifting their attention to CBD-based offerings, attracted by higher profit margins and sales. For instance, in March 2023, CV Sciences, Inc., a U.S.-based wellness company that sells hemp extracts and other natural ingredients, announced the addition of +PlusCBD Daily Balance THC-Free Gummies and Softgels to its product line, providing consumers with the wellness benefits of CBD. Such developments have become increasingly common in recent years, fueled by legalization and a positive stance from health authorities and governments in the industry.
Global CBD Consumer Health Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global CBD consumer health market report based on product, distribution channel, and region:Product Outlook (Revenue, USD Billion, 2021 - 2033)
- Medical OTC Products
▪ CBD Dermatology Products
▪ CBD Mental Health Products
▪ CBD Sleeping Aids Products
▪ Other OTC Products
- Nutraceuticals
▪ CBD Sports Nutrition
▪ CBD Weight Management and Wellbeing
Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
- Online Stores
- Retail Stores
- Retail Pharmacies
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
▪ Canada
▪ Mexico
- Europe
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
- Asia Pacific
▪ India
▪ China
▪ Australia
▪ South Korea
▪ Thailand
- Latin America
▪ Argentina
- Middle East & Africa
▪ Saudi Arabia
▪ UAE
▪ Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. CBD Consumer Health Market Variables, Trends, & Scope
Chapter 4. CBD Consumer Health Market: Product Estimates & Trend Analysis
Chapter 5. CBD Consumer Health Market: Distribution Channel Estimates & Trend Analysis
Chapter 6. CBD Consumer Health Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
- Elixinol
- ENDOCA
- NuLeaf Naturals, LLC
- Kazmira
- Charlotte's Web, Inc.
- Joy Organics
- The Cronos Group
- Medical Marijuana, Inc.
- CV Sciences, Inc.
- Isodiol International Inc.
